For disease modeling, CRISPR/Cas9 and TALEN approaches have successfully recapitulated human ocular pathologies including aniridia (Pax6 mutations), retinitis pigmentosa (RHO variants), and congenital cataracts (GJA8 defects). This evidence concerns the gene PAX6 and aniridia.